EUVIMEDEUVIMED entdecken
Vergleichsstudie

Uroprotective effect of diarylpropionitrile versus finasteride on rat model of testosterone-induced prostatic hyperplasia

Ahmed Khalafa Ali, Ahmed Rahmah Abu-Raghif, Hayder Ridha-Salman

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-04 · 399 (7) · 9937-9953

DOI: 10.1007/s00210-026-05044-y ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 28.01.2026. Verfasst von Ahmed Khalafa Ali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq. Hauptthemen laut MEDLINE: Finasteride, Nitriles, Prostatic Hyperplasia, Propionates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benign prostatic hyperplasia (BPH) is a common public health problem in ageing men worldwide. Diarylpropionitrile, a selective ERβ agonist, favorably regulates cell proliferation and inflammation, two major hallmarks of BPH pathology. This study aimed to explore the mitigative impact of diarylpropionitrile on testosterone-driven BPH in rats. 40 Sprague Dawley male rats aged 2.5-3 months were randomly divided into 4 groups (n = 10): a normal control group, a testosterone-induced BPH group, a finasteride-treated group, and a diarylpropionitrile-treated group. BPH was induced by daily subcutaneous testosterone injections for 4 weeks, with finasteride and diarylpropionitrile administered orally once daily for the same duration, one hour before each testosterone injection. After 4 weeks of treatment, macroscopic and microscopic features of prostatic hyperplasia and androgenic, proliferative, angiogenic, apoptotic, and inflammatory biomarkers in prostatic tissue homogenates were assessed. Testosterone administration significantly increased prostate weight, prostatic index, and hyperplasia scores, while treatment with either diarylpropionitrile or finasteride effectively ameliorated these testosterone-induced changes. Both treatments significantly lowered elevated prostatic DHT, 5αR2, β-catenin, and PCNA levels, demonstrating a strong anti-proliferative effect. They also attenuated the increased pro-inflammatory cytokines IL-6, IL-27, and PGE2 and growth factors TGF-β and VEGF. Furthermore, both agents inhibited testosterone-induced ERβ upregulation and increased expression of the anti-apoptotic protein BCL2. There were no substantial differences comparing finasteride and diarylpropionitrile in the majority of the tested parameters. Diarylpropionitrile alleviates testosterone-driven BPH in rats by modulating key pathways associated with cellular proliferation and inflammation. Diarylpropionitrile, as an ERβ agonist, represents a promising alternative for the BPH treatment through multi-targeted mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FinasterideNitrilesProstatic HyperplasiaPropionatesAnimalsMaleTestosteroneRats, Sprague-DawleyProstateDisease Models, AnimalRatsCell ProliferationEstrogen Receptor beta

Stichwörter der Autor:innen

BPHDiarylpropionitrileEstrogen receptorsFinasterideInflammationTestosterone

Substanzen

FinasterideNitrilesTestosterone2,3-bis(4-hydroxyphenyl)-propionitrilePropionatesEstrogen Receptor beta

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq.
  • College of Pharmacy, Al-Mustaqbal University, Hillah, Babylon, 51001, Iraq. hayder80.ridha@gmail.com.

Zitieren

APA

Ali, A. K., Abu-Raghif, A. R., & Ridha-Salman, H. (2026). Uroprotective effect of diarylpropionitrile versus finasteride on rat model of testosterone-induced prostatic hyperplasia. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(7), 9937-9953. https://doi.org/10.1007/s00210-026-05044-y

Vancouver

Ali AK, Abu-Raghif AR, Ridha-Salman H. Uroprotective effect of diarylpropionitrile versus finasteride on rat model of testosterone-induced prostatic hyperplasia. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(7):9937-9953. doi:10.1007/s00210-026-05044-y

BibTeX
@article{Ali2026,
  author = {Ali, Ahmed Khalafa and Abu-Raghif, Ahmed Rahmah and Ridha-Salman, Hayder},
  title = {Uroprotective effect of diarylpropionitrile versus finasteride on rat model of testosterone-induced prostatic hyperplasia},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {7},
  pages = {9937--9953},
  doi = {10.1007/s00210-026-05044-y}
}
Kostenlos starten →